Partner in the Firm's Global Intellectual Property Practice Group, Dimitrios' practice focuses on patent litigation and counselling, and technology transfer.
A registered US patent attorney, clients benefit from his representation in complex patent and technology-related disputes in the Patent Office, courts and before arbitration panels.
His extensive practice experience, which spans a period of 30 years, enables him to guide clients through often highly technical matters. Drawing on his previous background in biotechnology, he brings particular insight to IP issues in the life sciences sector.
In addition to his litigation practice, Dimitrios provides clients with advice on the acquisition and licensing of intellectual property rights, joint development agreements and strategic alliances.
Dimitrios has over 30 years of experience in intellectual property law and the resolution of complex commercial disputes. He has been lead trial counsel in patent litigations, patent antitrust litigations and arbitrations involving complex transactions and agreements. Some recent representative cases on which he was trial counsel are:
In re Lipitor Antitrust Litigation
Defending Pfizer in class action antitrust litigation: In re Lipitor Antitrust Litig., 46 F.Supp.3d 523 (D.N.J. 2014).
In re Effexor Antitrust Litigation
Defending Pfizer in class action antitrust litigation: In re Effexor XR Antitrust Litig., 2014 WL 4988410 (D.N.J. 2014).
Pfizer v. Teva et al.
Represented Pfizer as plaintiff in ANDA litigation against several generic manufacturers: Pfizer, Inc., et al. v. Teva Pharm. et al., 882 F.Supp.2d 643 (D. Del. 2012); aff'd, 109 USPQ 2d 1652 (Fed. Cir. 2014).
Interval Licensing v. Google
Defending Google in patent infringement litigation: Interval Licensing LLC v. AOL, Inc., 2012 WL 12247714 (W.D. Wash. 2012) aff'd in part, rev'd in part, 766 F.3d 1364 (Fed. Cir. 2014).
Apotex v. UCB
Defending UCB in patent infringement litigation: Apotex v. UCB, 970 F.Supp.2d 1297 (S.D. Fla. 2013); aff'd, 763 F.3d 1354 (Fed. Cir. 2014).
Pfizer v. Teva et al.
Represented Pfizer as plaintiff in ANDA litigation against several generic manufacturers: Pfizer v. Ivax, 2010 WL 339042 (D.N.J. 2010); 855 F.Supp.2d 286 (D.N.J. 2012).
IAM Patent 1000 (2019 - 2012): The World's Leading Patent Practitioners—Gold (top) ranking as Litigator
Legal 500: Patent Litigation (Life Sciences/Chemicals)
Chambers Global: United States Intellectual Property
Chambers USA: Intellectual Property (Patent)
PLC Which Lawyer?: Intellectual Property (Life Sciences and Patent Litigation)
Included in Best Lawyers® 2015 in the fields of Litigation—Intellectual Property and Litigation—Patent
Named to Law 360's 2014 "MVP" list of top lawyers in Life Sciences
Named to Law 360's 2013 "MVP" list of top lawyers in Life Sciences
Benchmark Litigation (2013): Local Litigation Star—New York; Litigation Star—United States, Intellectual Property